The impact of structured education on knowledge and self-efficacy in type 2 diabetes mellitus patients
Accepted: 20 December 2023
HTML: 15
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Patients diagnosed with Type 2 Diabetes Mellitus (T2DM) need to acquire knowledge and self-confidence to effectively engage in self-care activities. A structured education program has the potential to influence knowledge, self-efficacy, and self-care behavior. This study aimed to investigate the impact of education on the knowledge, self-efficacy, and self-care of individuals with T2DM. The research employed a quasi-experimental non-equivalent control group design with purposive sampling. The total sample size consisted of 60 participants, with 30 in each group. The intervention group attended a four-session T2DM structured education program conducted by internal medicine specialists, nurses, nutritionists, and pharmacists, while the control group continued with their usual monthly check-ups. The results of the independent t-test revealed differences in knowledge, self-efficacy, and self-care between the intervention and control groups in the post-test assessment. Education for T2DM patients was found to be effective in enhancing knowledge (p-value=0.000), self-efficacy (p-value=0.000), and self-care (p-value=0.000), making it a recommended component of self-management education to prevent complications. The implications of this study may assist hospitals in developing Standard Operating Procedures (SOPs) for implementing structured education programs for individuals with Type 2 Diabetes Mellitus as a means of enhancing patients’ management skills for T2DM.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.